0001213900-23-057083.txt : 20230714
0001213900-23-057083.hdr.sgml : 20230714
20230714160508
ACCESSION NUMBER: 0001213900-23-057083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230712
FILED AS OF DATE: 20230714
DATE AS OF CHANGE: 20230714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Timothy j
CENTRAL INDEX KEY: 0001767226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 231089149
MAIL ADDRESS:
STREET 1: 2690 DEVILS BACKBONE ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45233
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 NE MIZNER BLVD, SUITE 640
CITY: BOCA RATON
STATE: FL
ZIP: 33432
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 225 NE MIZNER BLVD, SUITE 640
CITY: BOCA RATON
STATE: FL
ZIP: 33432
4
1
ownership.xml
X0407
4
2023-07-12
0
0001711754
Inmune Bio, Inc.
INMB
0001767226
Schroeder Timothy j
C/O INMUNE BIO INC.
225 NE MIZNER BLVD., SUITE 640
BOCA RATON
FL
33432
1
0
0
0
1
Common Stock
2023-07-12
2023-07-12
4
S
0
10000
11.0085
D
82187
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 22, 2021.
The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions ranging from $11.00 to $11.10, inclusive. The reporting person undertakes to provide to Inmune Bio Inc., any security holder of Inmune Bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
These shares of common stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares.
/s/ Timothy Schroeder
2023-07-14